India has recorded one of the fastest expansions of bioeconomy worldwide, increasing from US$10 billion in 2014 to US$165.7 billion in 2024, as reported by
IANS, a partner of TV BRICS.
The sector is projected to reach US$300 billion by 2030, underscoring its role as a cornerstone of the country’s sustainable growth. The bioeconomy spans four major subsectors: BioIndustrial (47 per cent), BioPharma (35 per cent), BioAgri (8 per cent) and BioResearch (9 per cent).
Among the milestones of 2025, India has consolidated its position as a global leader in vaccine production, as reported by the source. The country has also achieved 20 per cent ethanol blending in petrol five years ahead of schedule, compared with only 1.5 per cent in 2014.
In August 2024, the Union Cabinet approved India’s first biotechnology policy, the BioE3 Policy (Biotechnology for Economy, Environment and Employment), to foster high-performance biomanufacturing and promote a shift towards regenerative and sustainable practices.
India’s bioeconomy is also viewed as a tool to mitigate climate change, supporting cleaner farming, carbon storage in agriculture, recycling, bioenergy use and greener industrial processes.
Photo: andreswd /
iStock
Самые
актуальные новости стран БРИКС https://tvbrics.com